Trials / Unknown
UnknownNCT02785146
Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 230 (estimated)
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, paralleled control clinical study investigating Huaier Granule for prevention of recurrence and metastasis of colorectal cancer after radical surgery, to evaluate the efficacy and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Huaier Granule | Huaier Granule is continuously taken three times per day, 20g per time. |
| DRUG | Oxaliplatin | 85 mg/m², ivdrip, D1 |
| DRUG | Calcium folinate | Calcium folinate 400 mg/m², ivdrip, D1; or calcium levofolinate, 200 mg/m², ivdrip, D1 |
| DRUG | 5-fluorouracil | 400 mg/m², iv, D1; and 2400mg/m², civ, 48h |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-01-01
- Completion
- 2018-06-01
- First posted
- 2016-05-27
- Last updated
- 2016-06-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02785146. Inclusion in this directory is not an endorsement.